As a growing body of research points to the potential for cannabis as a catalyst for climax, WH asks if this is the year that ...

Yeezy isn’t the only company being called out for its “bait-and-switch” Super Bowl commercial, a Californian company called ...

RR reader Liam Maynard feels that the thorny issue of Sunderland’s home attendances is something that can’t be ignored. Got ...

THE Welsh Open is closing in on a thrilling finale in Llandudno – and the four semi-finalists are now confirmed! Former world ...

U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...

We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at ...

Hims & Hers Health (NYSE: HIMS) is surging today. The stock is up 19%, and this is part of a broader 482.5% rally in the past year that has carried this telehealth company to nosebleed levels. Here’s ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A study published in JAMA Psychiatry enrolled 48 ...

Snoop Dogg and Tom Brady faced off for a Foundation to Combat Antisemitism Super Bowl ad, spewing hateful phrases during ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Hims & Hers' future growth is expected from personalized solutions, with potential to expand the subscriber base by millions.

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...